Skip to main content
SpringerLink
Log in
Book cover

Prognostic variables in node-negative and node-positive breast cancer

  • Book
  • © 1998

Overview

Editors:
  1. Giampietro Gasparini
    View editor publications

    You can also search for this editor in PubMed   Google Scholar

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (30 chapters)

  1. Front Matter

    Pages i-vi
    Download chapter PDF

  2. Prognostic variables in node-negative and node-positive breast cancer — Introduction

    • Giampietro Gasparini
    Pages 1-2

  3. Routinely available indicators of prognosis in breast cancer

    • David L. Page, Roy A. Jensen, Jean F. Simpson
    Pages 3-16

  4. Prognostic factors for patients with breast cancers 1cm and smaller

    • Yunn-Yi Chen, Stuart J. Schnitt
    Pages 17-33

  5. Steroid hormone receptors in breast cancer management

    • C. Kent Osborne
    Pages 35-46

  6. S-phase fraction combined with other patient and tumor characteristics for the prognosis of node-negative, estrogen-receptor-positive breast cancer

    • John Bryant, Bernard Fisher, Nurten Gündüz, Joseph P. Costantino, Birol Emir
    Pages 47-61

  7. S-phase fraction and breast cancer — a decade of experience

    • Charlotte R. Wenger, Gary M. Clark
    Pages 63-73

  8. Prognostic and predictive value of thymidine labelling index in breast cancer

    • D. Amadori, R. Silvestrini
    Pages 75-89

  9. Cyclin D1 in breast cancer

    • Diana M. Barnes, Cheryl E. Gillett
    Pages 91-105

  10. Cyclins and breast cancer

    • Patricia S. Steeg, Qun Zhou
    Pages 107-118

  11. Prognostic implications of expression of the cell cycle inhibitor protein p27kip1

    • Sandrine Cariou, Charles Catzavelos, Joyce M. Slingerland
    Pages 119-131

  12. The type 1 growth factor receptor family: new ligands and receptors and their role in breast cancer

    • William John Gullick, Radhika Srinivasan
    Pages 133-143

  13. c-erbB2 expression predicts tamoxifen efficacy in breast cancer patients

    • Sabino De Placido, Chiara Carlomagno, Michelino De Laurentiis, Angelo Raffaele Bianco
    Pages 145-154

  14. HER-2/neu as a predictive marker of response to breast cancer therapy

    • Mark D. Pegram, Giovanni Pauletti, Dennis J. Slamon
    Pages 155-167

  15. Prognostic and predictive value of p53 and p21 in breast cancer

    • Richard M. Elledge, D. Craig Allred
    Pages 169-188

  16. The urokinase plasminogen activator system as a target for prognostic studies in breast cancer

    • Ross W. Stephens, Nils Brünner, Fritz Jänicke, Manfred Schmitt
    Pages 189-201

  17. Metalloproteinases and tissue inhibitors of metalloproteinases

    • Masakazu Toi, Shinsuke Ishigaki, Takeshi Tominaga
    Pages 203-214

  18. Matrix metalloproteinase inhibitors

    • Peter D. Brown
    Pages 215-226

  19. The 67 kDa laminin receptor as a prognostic factor in human cancer

    • Sylvie Ménard, Elda Tagliabue, Maria Ines Colnaghi
    Pages 227-235

  20. Assessment of intratumoral vascularization (angiogenesis) in breast cancer prognosis

    • Ruth Heimann, Donald Ferguson, Stacy Gray, Samuel Hellman
    Pages 237-248
Back to top

Keywords

Bibliographic Information

  • Book Title: Prognostic variables in node-negative and node-positive breast cancer

  • Editors: Giampietro Gasparini

  • DOI: https://doi.org/10.1007/978-1-4615-5195-9

  • Publisher: Springer New York, NY

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer Science+Business Media Dordrecht 1998

  • Hardcover ISBN: 978-0-7923-8447-2Published: 28 February 1999

  • Softcover ISBN: 978-1-4613-7366-7Published: 08 October 2012

  • eBook ISBN: 978-1-4615-5195-9Published: 06 December 2012

  • Edition Number: 1

  • Number of Pages: VI, 428

  • Topics: Oncology

Publish with us

Policies and ethics

Back to top

Search

Navigation